 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - McMinn Rachel
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2016-05-02 Sale | 2016-05-04 9:00 pm | INTERCEPT PHARMACEUTICALS INC | ICPT | McMinn Rachel Chief Strategy Officer | 130 | $147.49 | $19,174 | 14,087 (Direct) | View |
| 2016-07-05 Sale | 2016-07-07 9:01 pm | INTERCEPT PHARMACEUTICALS INC | ICPT | McMinn Rachel Chief Strategy Officer | 106 | $145.11 | $15,382 | 13,986 (Direct) | View |
| 2016-08-01 Sale | 2016-08-02 9:00 pm | INTERCEPT PHARMACEUTICALS INC | ICPT | McMinn Rachel Chief Strategy Officer | 125 | $176.57 | $22,071 | 13,861 (Direct) | View |
| 2016-10-31 Sale | 2016-11-02 9:00 pm | INTERCEPT PHARMACEUTICALS INC | ICPT | McMinn Rachel Chief Strategy Officer | 129 | $123.82 | $15,972 | 13,732 (Direct) | View |
| 2017-01-03 Sale | 2017-01-05 9:00 pm | INTERCEPT PHARMACEUTICALS INC | ICPT | McMinn Rachel Chief Strategy Officer | 816 | $103.92 | $84,798 | 12,916 (Direct) | View |
| 2017-04-03 Sale | 2017-04-05 9:01 pm | INTERCEPT PHARMACEUTICALS INC | ICPT | McMinn Rachel Chief Strategy Officer | 257 | $115 | $29,554 | 17,659 (Direct) | View |
| 2017-05-01 Sale | 2017-05-03 9:01 pm | INTERCEPT PHARMACEUTICALS INC | ICPT | McMinn Rachel Chief Strategy Officer | 114 | $113.12 | $12,896 | 17,545 (Direct) | View |
| 2017-07-03 Sale | 2017-07-05 9:00 pm | INTERCEPT PHARMACEUTICALS INC | ICPT | McMinn Rachel Chief Strategy Officer | 257 | $121.78 | $31,297 | 17,288 (Direct) | View |
| 2017-07-31 Sale | 2017-08-02 8:59 pm | INTERCEPT PHARMACEUTICALS INC | ICPT | McMinn Rachel Chief Strategy Officer | 130 | $123.12 | $16,005 | 17,158 (Direct) | View |
| 2017-10-02 Sale | 2017-10-04 9:00 pm | INTERCEPT PHARMACEUTICALS INC | ICPT | McMinn Rachel Chief Strategy Officer | 283 | $58.89 | $16,667 | 16,875 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2017-02-01 Option Award | 2017-02-03 9:02 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC | ICPT | McMinn Rachel Chief Strategy Officer | 5,000 | $0 | 17,916 (Direct) | View |
| 2017-02-01 Option Award | 2017-02-03 9:02 pm | N/A 2027-02-01 | INTERCEPT PHARMACEUTICALS INC | ICPT | McMinn Rachel Chief Strategy Officer | 8,300 | $0 | 8,300 (Direct) | View |